摘要
根据国际糖尿病联盟(IDF)统计,2011年全球糖尿病患者为3.66亿,近年来我国糖尿病发病率迅速上升的严峻形势令人震惊。目前治疗糖尿病的药物主要为口服制剂和胰岛素制剂,而胰岛素制剂则是最直接和最有效的治疗方法,且市场份额逐年上升。所以,文章对胰岛素制剂的分类、市场现状等进行研究与分析,以期对我国相关产业的发展提供一定的现实意义。
According to the international diabetes federation（IDF）,the number of diabetes patients in the world is about 366 million.What a shocker is the situation that the diabetes prevalence had risen rapidly.At present,the diabetes drugs for the main treatment are oral preparations and insulin,the market share of insulin which is the most direct and effective treatment is increasing year by year.So,This paper is intended to analysis the the classification and the market situation of insulin,and offer some practical significance for the relevant industries in China.
出处
《北方药学》
2013年第5期110-111,共2页
Journal of North Pharmacy
基金
中央高校基本科研业务费专项资金资助(项目批准号JKY2011102)
关键词
胰岛素
竞争状况
重点企业
Diabetes drug Competition Key enterprise
